Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cilostazol Verse Asprin for Vascular Dementia in Poststroke Patients With White Matter Lesions
NCT00847860Phase 4Completed
- Sponsor
- Peking University First Hospital
- Start
- Mar 2008
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of cilostazol in vascular dementia (2 arms), sponsored by Peking University First Hospital. Primary endpoints: Mini-Mental State Examination at 1 year, Montreal Cognitive Assessment at 1 year and 2 more. Started Mar 2008; status: completed.
02
Drugs
cilostazol
03
Conditions
vascular dementia
Beyond the preview
Go deeper on NCT00847860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00847860.